Andrew Skingsley
- Virology top 5%
- HIV Research and Treatment 4
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 8
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 6
- Tuberculosis Research and Epidemiology 3
- Emergency Medicine top 5%
- Hospital Admissions and Outcomes 2
- Otorhinolaryngology top 10%
-
- Heparin-Induced Thrombocytopenia and Thrombosis 2
- Co-authors
- Valérie DelpechFiona BurnsAndrew CopasSarika DesaiSara CroxfordAlison BrownMeaghan KallMichael Edelstein
- Journals
- PLoS ONE (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Andrew Skingsley
22 papers receiving 584 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Virology 149
- Infectious Diseases 355
- Emergency Medicine 159
- Epidemiology 229
- Otorhinolaryngology 28
Countries citing papers authored by Andrew Skingsley
This map shows the geographic impact of Andrew Skingsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Skingsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Skingsley more than expected).
Fields of papers citing papers by Andrew Skingsley
This network shows the impact of papers produced by Andrew Skingsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Skingsley. The network helps show where Andrew Skingsley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Skingsley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2018 | 28 | |
| 10 | 2017 | 6 | |
| 11 | Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohortbreakdown → | 2016 | 273 |
| 12 | Monitoring HIV-Related Mortality in South Africa: The challenges and urgency | 2015 | 2 |
| 13 | 2014 | 29 | |
| 14 | 2014 | 13 | |
| 15 | 2014 | 6 | |
| 16 | 2014 | 1 | |
| 17 | 2013 | 49 | |
| 18 | 2013 | 44 | |
| 19 | High levels of drug resistance after failure of first-line antiretroviral therapy in rural South Africa: impact on standardised second-line regimens | 2012 | 1 |
| 20 | 2012 | 44 |
About Andrew Skingsley
Andrew Skingsley is a scholar working on Infectious Diseases, Virology and Emergency Medicine, having authored 25 papers that have together received 592 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers), HIV Research and Treatment (4 papers), Tuberculosis Research and Epidemiology (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers) and Hospital Admissions and Outcomes (2 papers). The work is most often cited by research in Virology (149 citations), Infectious Diseases (355 citations) and Emergency Medicine (159 citations). Andrew Skingsley has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Valérie Delpech, Fiona Burns, Andrew Copas, Sarika Desai, Sara Croxford, Alison Brown, Meaghan Kall, Michael Edelstein, Ann Sullivan and A. Kitching. Their work appears in journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.